| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
|
J Thorac Cardiovasc Surg
|
2013
|
2.65
|
|
2
|
Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
|
J Thorac Cardiovasc Surg
|
2012
|
2.23
|
|
3
|
Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
|
Chest
|
2014
|
1.98
|
|
4
|
Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
|
Cancer Res
|
2007
|
1.68
|
|
5
|
Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
|
Ann Thorac Surg
|
2013
|
1.51
|
|
6
|
Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
|
Cancer Res
|
2009
|
1.42
|
|
7
|
Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
|
Cancer Res
|
2007
|
1.42
|
|
8
|
Subpleural honeycombing on high resolution computed tomography is risk factor for fatal pneumonitis.
|
Ann Thorac Surg
|
2011
|
1.39
|
|
9
|
Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
|
Am J Clin Pathol
|
2007
|
1.33
|
|
10
|
Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.
|
Cancer Res
|
2010
|
1.31
|
|
11
|
Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
|
J Thorac Cardiovasc Surg
|
2011
|
1.28
|
|
12
|
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.
|
J Thorac Cardiovasc Surg
|
2011
|
1.12
|
|
13
|
Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer.
|
Clin Cancer Res
|
2011
|
1.11
|
|
14
|
Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas.
|
Lung Cancer
|
2002
|
1.07
|
|
15
|
Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma.
|
Chest
|
2007
|
1.07
|
|
16
|
Anterior mediastinal mass in a patient with Graves' disease.
|
Ann Thorac Surg
|
2006
|
1.04
|
|
17
|
Surgically curable peripheral lung carcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival.
|
Chest
|
2005
|
1.03
|
|
18
|
Correlations between thin-section CT findings, histopathological and clinical findings of small pulmonary adenocarcinomas.
|
Lung Cancer
|
2010
|
1.01
|
|
19
|
Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
|
J Thorac Cardiovasc Surg
|
2012
|
1.00
|
|
20
|
Rapid and simple detection of hot spot point mutations of epidermal growth factor receptor, BRAF, and NRAS in cancers using the loop-hybrid mobility shift assay.
|
J Mol Diagn
|
2006
|
0.99
|
|
21
|
Growth rate of lung cancer recognized as small solid nodule on initial CT findings.
|
Eur J Radiol
|
2011
|
0.99
|
|
22
|
Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.
|
Diagn Pathol
|
2012
|
0.95
|
|
23
|
Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
|
Anticancer Res
|
2002
|
0.91
|
|
24
|
Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: prognostic factors from CT findings.
|
Eur J Radiol
|
2010
|
0.90
|
|
25
|
Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src.
|
J Pathol
|
2010
|
0.89
|
|
26
|
WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors.
|
Lab Invest
|
2011
|
0.89
|
|
27
|
Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung.
|
Mod Pathol
|
2007
|
0.88
|
|
28
|
Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells.
|
Lab Invest
|
2013
|
0.88
|
|
29
|
Initial findings and progression of lung adenocarcinoma on serial computed tomography scans.
|
J Comput Assist Tomogr
|
2009
|
0.87
|
|
30
|
Prognosis of small adenocarcinoma of the lung based on thin-section computed tomography and pathological preparations.
|
J Comput Assist Tomogr
|
2008
|
0.86
|
|
31
|
Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
|
Proteomics
|
2009
|
0.85
|
|
32
|
Correlations of thin-section computed tomographic, histopathological, and clinical findings of adenocarcinoma with a bubblelike appearance.
|
J Comput Assist Tomogr
|
2010
|
0.83
|
|
33
|
Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
|
Am J Clin Oncol
|
2004
|
0.83
|
|
34
|
Micropapillary components in a lung adenocarcinoma predict stump recurrence 8 years after resection: a case report.
|
Lung Cancer
|
2013
|
0.83
|
|
35
|
SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women.
|
PLoS One
|
2013
|
0.83
|
|
36
|
Expression of vascular endothelial growth factor and basic fibroblast growth factor in small adenocarcinomas.
|
Oncol Rep
|
2001
|
0.83
|
|
37
|
Alveolar space filling ratio as a favorable prognostic factor in small peripheral squamous cell carcinoma of the lung.
|
Lung Cancer
|
2011
|
0.82
|
|
38
|
Decreased invasiveness via two methods of thoracoscopic lobectomy for lung cancer, compared with open thoracotomy.
|
Respirology
|
2007
|
0.82
|
|
39
|
Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.
|
Diagn Pathol
|
2011
|
0.82
|
|
40
|
Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
|
Eur J Radiol
|
2009
|
0.81
|
|
41
|
Case of solitary pulmonary capillary hemangioma: pathological features based on frozen section analysis.
|
Pathol Int
|
2013
|
0.81
|
|
42
|
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.
|
BMC Cancer
|
2014
|
0.80
|
|
43
|
Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method.
|
PLoS One
|
2013
|
0.80
|
|
44
|
Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma.
|
Medicine (Baltimore)
|
2015
|
0.79
|
|
45
|
Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma.
|
Eur J Radiol
|
2011
|
0.78
|
|
46
|
¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
|
Eur J Radiol
|
2013
|
0.78
|
|
47
|
Grade I lymphomatoid granulomatosis with increased uptake of [18F] fluorodeoxyglucose in positron emission tomography: a case report.
|
J Clin Exp Hematop
|
2009
|
0.78
|
|
48
|
Papillary adenoma of the lung with a peculiar raw macroscopic feature.
|
Pathol Int
|
2011
|
0.77
|
|
49
|
Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical course.
|
Lung Cancer
|
2010
|
0.76
|
|
50
|
Surgical outcomes and reevaluation of treatment strategies for thymomas.
|
Oncol Lett
|
2010
|
0.75
|
|
51
|
Outcomes of lobectomy in 'active' octogenarians with clinical stage I non-small-cell lung cancer.
|
Ann Thorac Cardiovasc Surg
|
2014
|
0.75
|
|
52
|
Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.
|
Ann Thorac Cardiovasc Surg
|
2016
|
0.75
|
|
53
|
A logistic regression predictive model and the outcome of patients with resected lung adenocarcinoma of 2 cm or less in size.
|
Lung Cancer
|
2008
|
0.75
|
|
54
|
Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma.
|
J Cardiothorac Surg
|
2015
|
0.75
|
|
55
|
The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT.
|
Respiration
|
2015
|
0.75
|
|
56
|
[Salvage Surgery for Residual and Recurred Tumor after Definitive Chemoradiotherapy].
|
Kyobu Geka
|
2017
|
0.75
|
|
57
|
[Surgical management of pulmonary metastases].
|
Gan To Kagaku Ryoho
|
2010
|
0.75
|
|
58
|
[The case of a solitary pulmonary tumor which could be diagnosed as early gastric cancer recurrence by detailed pathological examinations].
|
Gan To Kagaku Ryoho
|
2014
|
0.75
|